132 related articles for article (PubMed ID: 32391255)
21. Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis.
Chan AS; Cheung MC; Law SC; Chan JH
Cancer; 2004 Jan; 100(2):398-404. PubMed ID: 14716777
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
Chen JL; Huang YS; Kuo SH; Hong RL; Ko JY; Lou PJ; Wang CW
Oncotarget; 2017 Feb; 8(8):14068-14077. PubMed ID: 27764778
[TBL] [Abstract][Full Text] [Related]
23. [Study on DWMRI in evaluating the influence of intensity modulated radiotherapy on salivary gland function of nasopharyngeal carcinoma patients].
Li Y; Zhao C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 50(9):754-9. PubMed ID: 26696349
[TBL] [Abstract][Full Text] [Related]
24. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
[TBL] [Abstract][Full Text] [Related]
25. Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
Ng WT; Ngan RKC; Kwong DLW; Tung SY; Yuen KT; Kam MKM; Sze HCK; Yiu HHY; Chan LLK; Lung ML; Lee AWM
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):630-638. PubMed ID: 29413277
[TBL] [Abstract][Full Text] [Related]
26. Temporal Cerebral Microbleeds Are Associated With Radiation Necrosis and Cognitive Dysfunction in Patients Treated for Nasopharyngeal Carcinoma.
Shen Q; Lin F; Rong X; Yang W; Li Y; Cai Z; Xu P; Xu Y; Tang Y
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1113-20. PubMed ID: 27026315
[TBL] [Abstract][Full Text] [Related]
27. Normal Tissue Complication Probability Model for Radiation-induced Temporal Lobe Injury after Intensity-modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Zeng L; Huang SM; Tian YM; Sun XM; Han F; Lu TX; Deng XW
Radiology; 2015 Jul; 276(1):243-9. PubMed ID: 25658039
[TBL] [Abstract][Full Text] [Related]
28. Temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma: 1H MR spectroscopic findings.
Chong VF; Rumpel H; Aw YS; Ho GL; Fan YF; Chua EJ
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):699-705. PubMed ID: 10524425
[TBL] [Abstract][Full Text] [Related]
29. Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion.
Liao S; Xie Y; Feng Y; Zhou Y; Pan Y; Fan J; Mi J; Qin X; Yao D; Jiang W
J Cancer Res Clin Oncol; 2020 Feb; 146(2):429-439. PubMed ID: 31677113
[TBL] [Abstract][Full Text] [Related]
30. Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis.
Cheung M; Chan AS; Law SC; Chan JH; Tse VK
Arch Neurol; 2000 Sep; 57(9):1347-52. PubMed ID: 10987903
[TBL] [Abstract][Full Text] [Related]
31. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma.
Lee AW; Foo W; Chappell R; Fowler JF; Sze WM; Poon YF; Law SC; Ng SH; O SK; Tung SY; Lau WH; Ho JH
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):35-42. PubMed ID: 9422555
[TBL] [Abstract][Full Text] [Related]
32. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.
Tian YM; Guan Y; Xiao WW; Zeng L; Liu S; Lu TX; Zhao C; Han F
Head Neck; 2016 Feb; 38(2):225-31. PubMed ID: 25244494
[TBL] [Abstract][Full Text] [Related]
33. Surgical techniques in radiation induced temporal lobe necrosis in nasopharyngeal carcinoma patients.
Alfotih GT; Zheng MG; Cai WQ; Xu XK; Hu Z; Li FC
Neurol Neurochir Pol; 2016; 50(3):172-9. PubMed ID: 27154443
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
[TBL] [Abstract][Full Text] [Related]
35. Incidence and dosimetric parameters for brainstem necrosis following intensity modulated radiation therapy in nasopharyngeal carcinoma.
Li YC; Chen FP; Zhou GQ; Zhu JH; Hu J; Kang DH; Wu CF; Lin L; Wang XJ; Ma J; Sun Y
Oral Oncol; 2017 Oct; 73():97-104. PubMed ID: 28939083
[TBL] [Abstract][Full Text] [Related]
36. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital's experience.
Jiang F; Jin T; Feng XL; Jin QF; Chen XZ
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C179-84. PubMed ID: 26506872
[TBL] [Abstract][Full Text] [Related]
38. Radiation-induced abnormal cortical thickness in patients with nasopharyngeal carcinoma after radiotherapy.
Lin J; Lv X; Niu M; Liu L; Chen J; Xie F; Zhong M; Qiu S; Li L; Huang R
Neuroimage Clin; 2017; 14():610-621. PubMed ID: 28348952
[TBL] [Abstract][Full Text] [Related]
39. Concurrent Chemoradiotherapy versus Intensity-modulated Radiotherapy Alone for Elderly Nasopharyngeal Carcinoma Patients with Pre-treatment Epstein-Barr Virus DNA: A Cohort Study in an Endemic Area with Long-term Follow-up.
Yang Q; Zhao TT; Qiang MY; Hu L; Lv X; Ye YF; Ke LR; Yu YH; Qiu WZ; Liu GY; Huang XJ; Li WZ; Lv SH; Sun Y; Zhang LY; Pei F; Guo X; Xiang YQ; Qian CN; Huang BJ; Xia WX
J Cancer; 2018; 9(17):3023-3031. PubMed ID: 30210624
[No Abstract] [Full Text] [Related]
40. Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up.
Chen YY; Zhao C; Wang J; Ma HL; Lai SZ; Liu Y; Han F; Lu LX; Bao Y; Chen M
Cancer; 2011 Jul; 117(13):2910-6. PubMed ID: 21264821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]